It looks like Clarus Ventures is planning to reload with investment capital for life science companies.
The Boston- and San Francisco-based venture firm revealed in a SEC filing it’s looking to raise up to $375 million for a third fund.
In a recent post at In the Pipeline, Derek Lowe answers a reader’s question about how best to promote drug discover in India. Given my research on the matter, I figured I would try and provide an answer as well.
In Scientific American’s Worldview, I have been ranking national biotechnology industries for the past five years. When I was recently in New Delhi I presented the Indian innovation figures and asked the audience to guess where they ranked. Much to their amazement, India was ranked with the bottom five of the 50+ countries assessed. The issues are myriad — poor patent protection, infrastructure problems, an insufficient quantity (not quality!) of skilled workers, etc.
Rockville-based MacroGenics Inc. plans to sell 2.5 million shares in a secondary offering, the bulk of which would go toward advancing the biotech’s oncology drug candidates through the clinic and expanding its manufacturing capacity.
Much like in MacroGenics’ October initial public offering, the chief purpose of this offering is to fund the pipeline, with 1.5 million shares offered by the company and another 1 million shares coming from selling shareholders.
A recent third-party economic development impact study conducted by Battelle Technology Partnership Practice (TPP), the world’s largest non-profit research and development organization, has found that the Maryland Technology Development Corporation (TEDCO) currently supports more than $565.9 million in economic contributions and more than 2,835 jobs in the State of Maryland annually, earning $200.5 million in salaries with estimated State and local government revenues of $22.8 million. The study also determined the economic contribution of TEDCO programs is projected to grow to $910.3 million and support a total of 4,527 jobs by 2018. These jobs will earn $320.3 million in salaries with estimated State and local government revenues of $36.6 million.
By Suzanne Raheb, Corporate Supplier Diversity Leader, Lockheed Martin Corporation
Whether working as a subcontractor or a technology mentor, Lockheed Martin provides small businesses with various assistance during different phases of their SBIR/STTR projects. This includes supporting technology requirements, evaluation, co-development, and insertion into larger systems.
Bethesda-based Sucampo named former MedImmune president Peter Greenleaf to serve as the company’s chief executive starting next month, according to a news release.
The appointment brings a high-profile name to the biotechnology firm as it looks to commercialize products for glaucoma and constipation, as well as develop additional drugs to treat eye and digestive issues.
Through the Open Innovation Challenge, the American Heart Association hopes to get closer to its goal of improving Americans’ cardiovascular health by 20 percent by 2020.
The key to crowdfunding success? Pull at the heartstrings of your audience.
That’s what the New York City affiliate of the American Heart Association aims to do in its first-ever Open Innovation Challenge, a program that is part of the AHA’s Health Science Innovation and Investment Forum.
Declines in budgets across the public health community were just one reason the Centers for Disease Control and Prevention began looking at innovative approaches for employees and partners to collaborate online.
With the agency’s health informatics partners stretching to state and local public health departments, academics, educational institutions, standards organizations, as well as other countries, CDC in 2009 began examining how it could develop a more cost-effective and efficient way for these key stakeholders to meet, collaborate and advance new ideas.
HHS is committed to implementing all the provisions of the SBIR/STTR Reauthorization Act of 2011 (P.L. 112-81). NIH has set up a website to keep the small business research community abreast of its implementation plan for the many changes resulting from the reauthorization. The site will be updated as the implementation process moves forward.
This issuance implements an additional provision of the Reauthorization Act.
TechConnect is pleased to host 2014 TechConnect World, June 15-19 in Washington DC. The event, co-located with the 2014 National Innovation Summit the 2014 National Small Business Innovation Research (SBIR) Conference, delivers the world’s largest showcase and accelerator for industry-vetted emerging-technologies ready for commercialization.
Don’t miss this opportunity to place your technology, your company, or your agency’s awardee portfolio into the TechConnect Innovation Showcase and Accelerator program to be matched with the world’s largest gathering of potential investment and corporate partners.